Authors have shown that the loss-of-function mutation of PPARγ results in severe insulin resistance and causes elevated TG and decreased high density lipoprotein-cholesterol levels in humans while increased PPARγ activity enhances insulin sensitivity and improves dyslipidemia in insulin-resistant individuals [11]. The gene discussed is INS; the disease is Insulin resistance.